Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Early recognition and treatment of VATS in transplant patients improve outcomes.

Baricitinib successfully treated severe hair loss.

Baicapil was effective in reducing hair loss and increasing hair growth in women with telogen effluvium.

Pili torti is a rare condition where hair is twisted and breaks easily, often linked to genetic disorders or other health issues.

A defective gene causes hair loss and taste insensitivity in BTBR mice.

ATR12-351 ointment safely delivers LEKTI protein to the skin, reducing enzyme activity in Netherton syndrome.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Baricitinib is effective and safe for treating alopecia areata.

Ritlecitinib was generally well tolerated in children with alopecia areata.

Sirolimus effectively reduces lesions and improves quality of life in Blue Rubber Bleb Nevus Syndrome with manageable side effects.

Green betel leaf extract cream helps improve hair growth and health.

DNCB is more effective than betamethasone for hair regrowth but has more side effects.

Brunsting-Perry pemphigoid can cause scarring hair loss and may be underdiagnosed.

The best biotin hair tonic formula has 20% span 80, 9.47% tween 80, and 5% PEG 400.

Clinicians should consider individual factors and communicate risks and benefits when prescribing ritlecitinib for adolescent alopecia areata.

Topical methotrexate is more effective and as safe as betamethasone for treating alopecia areata.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

Biotin helps maintain hair follicle growth by affecting cell death and survival signals.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

A patient had both white piedra and head lice, showing their differences.

Baricitinib effectively treated alopecia areata in 73% of patients, with minor metabolic changes and significant changes in inflammatory markers.

Baricitinib is effective and safe for treating severe alopecia areata.

Beta-blockers can cause rare skin side-effects, which usually improve after stopping the medication.

Nilotinib can cause generalized keratosis pilaris.

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.

RV3466F lotion significantly reduces hair loss and improves acute telogen effluvium.